EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Neurobiological Characterization of Barbamide and Analogs

Christian K. Fofie, Meenakshi Sharma, Mandee K. Schaub, Katie T. Ward, Gionathan E. Zavala, Kylie S. Wells, Natalia Valderrama Pena, Sreya S. Iyer, Patrick Walsh, Gregory Dussor, Benedict J. Kolber, Kevin J. Tidgewell

ACS Chemical Neuroscience · 27.10.2026

DOI: 10.1021/acschemneuro.6c00641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 27.10.2026. Verfasst von Christian K. Fofie und 11 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Institutes of Health (NIH).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marine cyanobacteria produce diverse secondary metabolites, which have biological activity on the human nervous system. We report evaluation of the cyanobacterial metabolite barbamide and analogs in the modulation of sensory neurons. We optimized synthesis of barbamide and an initial series of analogs with modifications of the trichloromethyl group to explore its role in function as well as simplify future synthetic efforts. Biological activity of this series was first evaluated using a multi-electrode array assay with human induced pluripotent stem cell nociceptors. We found that all three compounds were able to reduce neuronal firing rates in a dose-dependent manner consistent with potential use as an analgesic. Next, barbamide was further evaluated using primary human sensory neurons with whole cell patch clamp to gain insight into the mechanism driving the reduction in neuronal firing rate. We found that barbamide significantly decreased spontaneous and evoked action-potential firing in these neurons without overt toxicity. Finally, we evaluated the impact of barbamide on neurite outgrowth using PC12 cells and primary mouse dorsal root ganglia. We found that barbamide and trifluoromethyl barbamide increased neurite outgrowth. Together, this combination of effects further establishes the potential of the barbamide scaffold for the development of therapeutics focused on neuronal function/dysfunction.

Förderung

  • National Institutes of Health (NIH)

Zitieren

APA

Fofie, C. K., Sharma, M., Schaub, M. K., Ward, K. T., Zavala, G. E., Wells, K. S., Pena, N. V., Iyer, S. S., Walsh, P., Dussor, G., Kolber, B. J., & Tidgewell, K. J. (2026). Synthesis and Neurobiological Characterization of Barbamide and Analogs. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.6c00641

Vancouver

Fofie CK, Sharma M, Schaub MK, Ward KT, Zavala GE, Wells KS, et al. Synthesis and Neurobiological Characterization of Barbamide and Analogs. ACS Chemical Neuroscience. 2026. doi:10.1021/acschemneuro.6c00641

BibTeX
@article{Fofie2026,
  author = {Fofie, Christian K. and Sharma, Meenakshi and Schaub, Mandee K. and Ward, Katie T. and Zavala, Gionathan E. and Wells, Kylie S. and Pena, Natalia Valderrama and Iyer, Sreya S. and Walsh, Patrick and Dussor, Gregory and Kolber, Benedict J. and Tidgewell, Kevin J.},
  title = {Synthesis and Neurobiological Characterization of Barbamide and Analogs},
  journal = {ACS Chemical Neuroscience},
  year = {2026},
  doi = {10.1021/acschemneuro.6c00641}
}
Kostenlos starten →